Your reference journal for coronary, valvular and structural interventions

Articles

10.4244/EIJV7I1A1 • May 17, 2011

In memoriam Otto Martin Hess, MD

Meier B

free

10.4244/EIJV7I1A2 • May 17, 2011

The rites of spring

Serruys PW

free

10.4244/EIJV7I1A3 • May 17, 2011

Indirect mitral annuloplasty: a feasible or a mirage technology

Ruiz C, Sánchez-Quintana D

free

10.4244/EIJV7I1A4 • May 17, 2011

Patrick W. Serruys and the roots of PCR

Marco J, Doncieux M

free

10.4244/EIJV7I1A5 • May 17, 2011

Patrick Washington Serruys: a view from across the Atlantic

King S

free

10.4244/EIJV7I1A6 • May 17, 2011

The concept of participatory learning group development

Dompeix C, Bréhèret M, Spencer A, Marco J

free

10.4244/EIJV7I1A7 • May 17, 2011

EuroPCR May 2011 plenary session: coronary revascularisation, Asia Pacific perspectives

Lim Y

free

• May 17, 2011

Patrick W. Serruys and the EAPCI

Di Mario C

free

10.4244/EIJV7I1A9 • May 17, 2011

Transapical versus transfemoral aortic valve implantation

Robb J, Wendler O

free

10.4244/EIJV7I1A10 • May 17, 2011

Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines

Gurvitch R, Toggweiler S, Willson A, Wijesinghe N, Cheung A, Wood DA, Ye J, Webb JG

free

10.4244/EIJV7I1A11 • May 17, 2011

Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era

Tissot C-M, Attias D, Himbert D, Ducrocq G, Iung B, Dilly M-P, Juliard J, Lepage L, Détaint D, Messika-Zeitoun D, Nataf P, Vahanian A

free

10.4244/EIJV7I1A12 • May 17, 2011

Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance

Sherif M, Abdel-Wahab M, Beurich H-W, Stöcker B, Zachow D, Geist V, Tölg R, Richardt G

free

10.4244/EIJV7I1A13 • May 17, 2011

Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial

Silber S, Gutiérrez-Chico J-L, Behrens S, Witzenbichler B, Wiemer M, Hoffmann S, Slagboom T, Harald D, Suryapranata H, Naber CK, Nienaber C, Chevalier B, Serruys PW

free

10.4244/EIJV7I1A14 • May 17, 2011

Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials

Kereiakes D, Smits PC, Kedhi E, Parise H, Fahy M, Serruys PW, Stone GW

free

10.4244/EIJV7I1A15 • May 17, 2011

PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses

Meredith I, Whitbourn R, Scott D, El-Jack S, Zambahari R, Stone GW, Teirstein P, Starzyk R, Allocco DJ, Dawkins K

free

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Readers

Current issue